Homemyovaterra.comcrumbs.beyond-the-main-st...
Logo
Nov 17, 2026 6:01 PM

Beyond the Main Stage at FRMC 2026

Shop now
Beyond the Main Stage at FRMC 2026
Nov 17, 2026 6:01 PM

Beyond the Main Stage at FRMC 2026

Shop now

Beyond the Main Stage at FRMC 2026

Overview of the Newsletter

The newsletter from the Foundation for Reproductive Medicine (FRM) promotes the Foundation for Reproductive Medicine Conference (FRMC 2026), scheduled for December 4 to 6, 2026, at the Metropolitan Club, One East 60th Street, New York City. Its central message is that some of the most valuable discoveries at a scientific conference come from research that has not yet become part of everyday clinical practice. The email highlights a set of oral research presentations that will take place beyond the main lecture hall, giving attendees a closer look at emerging findings and approaches.

On Saturday, December 5, the Governor's Room at the Metropolitan Club will host 20 accepted oral research presentations. These presentations bring together investigations from institutions across the United States and around the world. According to the newsletter, they are intended to help attendees explore new findings, examine emerging methods, and consider questions that could shape the future of reproductive medicine.

Highlighted Research Questions

The newsletter previews four examples from the oral research program:

  • Fairer IVF success evaluation: Researchers from the United Kingdom will present a prognosis-based approach to benchmarking IVF outcomes against predicted probabilities, asking whether success rates can be assessed more fairly.
  • Changes in fertility treatment: A study using six years of German IVF registry data will examine how reproductive care and its outcomes are evolving in clinical practice.
  • AI and genomics in embryo prioritization: Research from Taiwan will explore an integrated approach that combines genomic information with artificial intelligence to help prioritize embryos.
  • Nurse practitioner-led fertility care: A U.S. study will compare outcomes from a nurse practitioner-led fertility practice with national benchmarks.

The newsletter describes these as only a sample of the questions in this year's program. The presentations are framed as an opportunity to see current research and to discuss its implications with the scientific and clinical community. The email notes that the audience includes physicians, researchers, embryologists, nurses, and other reproductive medicine professionals, and emphasizes that the value lies both in hearing established experts and in discovering work that may spark tomorrow's most important conversations.

Event Details and Registration

The newsletter lists the following registration rates for FRMC 2026, with no additional fees in any category:

  • Physicians (commercial): $1,350
  • Academics, lawyers, and investors: $850
  • Residents, fellows, and nurse practitioners: $850
  • Patients (current and former CHR patients): $500
  • Medical students: free

Faculty

The email invites readers to meet an international faculty described as bringing new perspectives, groundbreaking research, and thought-provoking discussions. Named speakers include G. David Adamson, David F. Albertini, Christine S. Allen, Todd Lencz, Milton K. H. Leong, Gil G. Mor, Claus Yding Andersen, Samuel F. Bakhoum, David H. Barad, Raoul Orvieto, Kyle Orwig, Ali H. Brivanlou, Amander T. Clark, Colin Conine, Pasquale Patrizio, David Pépin, Vardit Ravitsky, Dieter Egli, Allison Freeman, Sonia Gayete-Lafuente, David Seifer, Emre U. Seli, Zeev Shoham, Norbert Gleicher, Eriona Hysolli, Juan Carlos Izpisua-Belmonte, Hugh M. Taylor, Zev Williams, Nikica Zaninovic, Chaim Jalas, Eldin Jašarević, and Joanne Kwak-Kim.

Sponsors and Exhibitors

Ferring Pharmaceuticals is listed as the Gold Sponsor. The newsletter also names other sponsors and exhibitors, including Reproductive Times, Center for Human Reproduction (CHR), Ovaterra, Natera, ViaCord, Revvity, and Labcorp.

Products

The newsletter does not provide details about specific products. Ovaterra is listed among the sponsors and exhibitors with the tagline "Revolutionizing Fertility Health," and Natera appears with the tagline "Conceive. Deliver. Thrive." However, the email contains no product names, features, pricing, or descriptions for any of these companies, so no product information can be reliably reported from this text.

About the Store: myovaterra.com

The newsletter identifies Ovaterra as a sponsor and exhibitor at FRMC 2026, with the description "Revolutionizing Fertility Health." This is the only information the email provides about the company behind the domain myovaterra.com. The newsletter does not describe its catalog, online store, business model, or customer offerings. Based on the available text, Ovaterra positions itself in the fertility health field and chose to take part in a major reproductive medicine conference, which suggests an interest in engaging with the professional and clinical community. Readers who want to learn more about the company's offerings would need to visit myovaterra.com directly, as the newsletter does not contain further details.

Relevant newsletters

A Healthier Approach to Everyday Wellness

A Healthier Approach to Everyday Wellness

Nov 16, 2026 3:00 PM
myovaterra.com
Read now
Should Every Embryo Reach the Blastocyst Stage?

Should Every Embryo Reach the Blastocyst Stage?

Nov 12, 2026 6:12 PM
myovaterra.com
Read now
This Thanksgiving, Thank Your Body

This Thanksgiving, Thank Your Body

Nov 11, 2026 2:30 PM
myovaterra.com
Read now